Keisha Ray, PhD, was interviewed recently for a National Geographic article. The piece, titled “The Complex Debate Over How to Equitably Distribute the Different Vaccines” and authored by Jillian Kramer, includes concerns about the rollout of Pfizer and Moderna vaccines, noting the Johnson & Johnson vaccine may be a more logical choice, for members of marginalized and vulnerable communities.
In the article, Ray explains that access—not just vaccine hesitancy—accounts for fewer Black and Latino Americans receiving a COVID-19 vaccine. These individuals often work low-income jobs without paid time-off, making it difficult to receive a two-dose vaccine. The one-dose vaccine from Johnson & Johnson, however, may help address such access issues.